"You should take a look at the annual Antigen-Specific Immune Tolerance Conference. I’ve found it to be a great place to hear in a very focused way on emerging technologies as well as the latest preclinical and clinical learnings around the induction of antigen-specific tolerance. It’s an intimate meeting that allows for lots of opportunities for 1:1 interactions with startup leadership as well as our big biopharma peers working in this space. I think it would make sense for us to have a presence at this meeting."

Past Attendee, Amgen